We are happy to announce that our colleagues from MiWendo Solutions have received a total of 2.8M€ funding from the EIC Accelerator (ex SME Instrument Phase 2). Thanks to this funding, the company can now clinically validate its technology at the Hospital Clínic de Barcelona and begin its industrialization. MiWEndo Solutions is a medical start-up focused…
Inveniam Group is delighted kick-off the INCUBIS H2020 project last week to promote #IndustrialSymbiosis in the EU. The three-year EU funded project will establish five regional Incubators in Barcelona, Hull, Norway, Dunkirk and North Germany, to facilitate…
Pharmacelera
Spain
Inveniam supported the company in winning an EIC Accelerator grant
Public Funding from EU
Public Funding 2020
Socrates Consortium
Spain
Inveniam supported in the presentation for the Interactive Technologies call
Public Funding from EU
Public Funding 2020
As part of Capital Cell interviews of #LifeAfterCovid, our partner Albert Cot shares his view on how the world will be after the coronavirus crisis and how this pandemic will transform the way we do business. Albert emphasizes that the health system is a basic system that needs to be strengthened and it is one…
We are happy to announce that our colleagues from Pharmacelera have been granted with 1M€ by EIC Accelerator (ex SME Instrument Phase 2).
Inveniam has advised Devicare in the round and the closing of a successful transaction with Successful Ventures.
Successful Ventures is a business angels network with more than 100 active investors. In 2019, it has invested 1.8 million euros in 15 technology-based start-ups, and now is starting its journey in the e-health sector with the help of the leading Spanish company in urology, Devicare.
Devicare
Spain
Inveniam advised the Series A round with Successful Ventures and Ship2B
Equity Fundraising
Financial Services & Transaction Advisory 2020
Existen muchas oportunidades de financiación pública no diluida para PYMEs y Start-ups, pero estas son extremadamente competitivas. ¿Sabe cuáles son las más apropiadas para su empresa? ¿Sabe si tiene posibilidades de ganar?
ZeClinics Therapeutics is a biopharmaceutical company focused on the development of treatments for cardiovascular diseases. Nowadays cardiovascular diseases are the cause of death of at least a third of the global population. Despite this issue, there is not enough research on this area because all the focus is on fighting cancer. ZeClinics proposes a revolutionary…